Exact Sciences Corporation
EXAS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,594 | -$1,185 | -$101,215 | -$864,585 |
| Dep. & Amort. | $55,882 | $55,283 | $54,061 | $53,147 |
| Deferred Tax | $501 | -$6 | -$1,007 | -$11,946 |
| Stock-Based Comp. | $0 | $55,783 | $54,618 | $49,203 |
| Change in WC | $120,206 | -$34,354 | -$1,840 | -$21,472 |
| Other Non-Cash | $62,928 | $13,496 | $26,192 | $842,716 |
| Operating Cash Flow | $219,923 | $89,017 | $30,809 | $47,063 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$29,897 | -$42,342 | -$31,174 | -$36,316 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$96,762 | -$14,256 | -$80,315 | -$60,461 |
| Inv. Sales/Matur. | $40,053 | $252,872 | $77,557 | $54,905 |
| Other Inv. Act. | $152 | $28,621 | -$505 | $0 |
| Investing Cash Flow | -$86,454 | $224,895 | -$34,437 | -$41,872 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$249,172 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,532 | -$4,514 | -$6,999 | $10,499 |
| Financing Cash Flow | -$1,532 | -$4,514 | -$256,171 | $10,499 |
| Forex Effect | $1 | $574 | $290 | -$3,721 |
| Net Chg. in Cash | $131,938 | $309,972 | -$259,509 | $11,969 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $657,099 | $347,127 | $606,636 | $594,667 |
| End Cash | $789,037 | $657,099 | $347,127 | $606,636 |
| Free Cash Flow | $190,026 | $46,675 | -$365 | $10,747 |